OrthoPediatrics Corp.
As of Oct 22, 2026, OrthoPediatrics is in Stage 2, the uptrend phase, now in week 17 (since Jun 30, 2026). It closed at $24.71, 6.8% below its 52-week high and above its 200-day average, which is rising.
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic con… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 35 in Medical Devices · #1 of 272 in Health Care
Is KIDS early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
KIDS among Medical Devices23rd of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …23 | KIDS | Stage 2 · wk 17 | 81 | +10.7% |
OrthoPediatrics: quick answers
What stage is OrthoPediatrics in?
As of Oct 22, 2026, OrthoPediatrics (KIDS) is in Stage 2, the uptrend phase. It entered Stage 2 on Jun 30, 2026 and is in week 17. What the four stages mean
Is OrthoPediatrics in an uptrend?
Yes. OrthoPediatrics is in a Stage 2 uptrend. It trades 28.1% above its 200-day average, which is rising.
How far is OrthoPediatrics from its 52-week high?
OrthoPediatrics closed at $24.71 on Oct 22, 2026, 6.8% below its 52-week high of $26.50. Its 52-week low is $14.64.
How has OrthoPediatrics performed over the past year?
As of Oct 22, 2026, OrthoPediatrics is up 38.0% over the past year and up 40.7% so far in 2026.
Which sector and industry is OrthoPediatrics in?
OrthoPediatrics is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, Mitchell Ponseti, VerteGlideTM, and Boston Brace 3D. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.